Objective. Histiocytic sarcoma (HS) is an extraordinary rare tumor and it has an offensive clinical course. HS of the uterine cervix is a far uncommon tumor with just a few cases described so far. Here we presented a case of primary HS of the uterine cervix in a 62-year-old female initially misdiagnosed as large cell non-keratinizing squamous cell carcinoma. To the best of our knowledge, this is the first reported case of HS of the uterine cervix from Iran.
INTRODUCTION
Histiocytic sarcoma (HS), previously defined as true histiocytic lymphoma is an uncommon offensive tumor. It comprises less than 1% of all non Hodgkin lymphomas [1] . Histiocytic sarcoma is designated as a malignant tumor consisting of cells with some characteristic features of normal histiocytes [2] . It is identified as one of six subgroups of dendritic lineage tumors. Dendritic lineage tumors comprise follicular dendritic cell sarcoma, interdigitating cell sarcoma, Langerhans cell sarcoma, Langerhans cell histiocytosis, and dendritic cell sarcoma NOS [3] . Nowadays the word "true histiocytic lymphoma" is equivalent to histiocytic sarcoma. Majority of the patients of HS are adult males. The most common primary sites of involvement are lymph nodes, skin and gastrointestinal tract [4] . Cervical HS is extremely rare. Therefore diagnosis of HS is based on morphologic aspects and exclusion of other similar neoplasms by immunohistochemistry (IHC) methods. Due to miss of knowledge of such an uncommon entity of ten these cases usually undergo a wide surgical excision. Here we present a case of primary HS of the uterine cervix in a 62-year-old female, initially misdiagnosed as nonkeratinizing squamous cell carcinoma.
CASE REPORT
A 62 year-old multiparous lady presented at another hospital with complaint of post-menopausal vaginal bleeding. Pelvic examination revealed a relatively large uterine cervical mass which was biopsied. The pathology report was a large cell nonkeratinizing squamous cell carcinoma. The patient subsequently referred to Department of Obstetrics and Gynaecology in our Hospital. Her pelvic examination showed a smooth cervical mass of about 9×5×3cm. Laboratory results were unremarkable. Then total abdominal hysterectomy and bilateral salpingoophorectomy were performed. The specimen was sent to the Department of Pathology for histological evaluation. Macroscopically, the specimen consisted of a cervix, uterus, and bilateral tubo-ovaries. The uterus measured 5 cm×4.5 cm×3 cm. The cervix contained an irregular pinkish-grey mass with a diameter of 6 cm. The endometrium was thin and unremarkable grossly and an intramural 1 cm leiomyoma was also present in the myometrium. Microscopically, the wall of the cervix was infiltrated by malignant cells, but the squamous epithelium and endocervical glands were intact. The tumor cells were relatively large and had pleomorphic nuclei with fine chromatin and bizarre silhouettes with eminent nucleoli. The cytoplasm was abundant and eosinophilic. There were foci of tumor necrosis. Immunohistochemically, the neoplastic cells expressed CD45, CD68 but were negative for CD20, HMB45, S100 and CKAE1/AE3. The histological and immunohistochemical results were compatible with HS arising in the cervix. The endometrium and bilateral tuboovaries were not involved. Review of outside slides related to previous cervical biopsy was done and confirmed the diagnosis of HS.
She was referred for further management of the disease to the hemato-oncologist. Chest radiography and abdominal ultrasonography were unremarkable. Contrast-enhanced CT of the neck, thorax and abdomen were performed. No pathological lymphadenopathy was noted. As a result the final diagnosis was primary HS of the uterine cervix. She received 6 cycles of chemotherapy (CHOP). Radiotherapy was done in her hometown. The patient status is stationary.
DISCUSSION
Mathe et al. explained histiocytic sarcoma for the first time in 1970 [5] . HS is a rare tumor of obscure cause [1] . HS most often occurs at a mean age of 46years years [6] . This disease is usually seen in males [1] . Our patient was a 62-year-old lady. Clinical presentation varies from solitary lesion to widely spread disease [7] . It frequently involves the gastrointestinal tract, the skin, and lymph nodes. In fact enlarged lymph node is the most common exhibition. Salivary gland, lung, liver, central nervous system, bone marrow and thyroid are other sites of involvement [8] . Primary cervical HS is an extremely uncommon diagnosis. Patients usually present with abnormal vaginal bleeding, abdominal mass or pelvic pain. The tumor presents as a quickly growing lump involving the uterine cervix. Microscopically, the tumor is composed by proliferation of large round to ovoid cells which are non-cohesive [9] . The correct diagnose is rests on the confirmation of the histiocytic nature and the exclusion of other entities such as diffuse large cell lymphoma, anaplastic large cell lymphoma, large cell carcinoma and melanoma [10] . Final differentiations can be made by immunohistochemistry (IHC) methods. Immunohistochemically, histiocytic sarcoma is identified by the expression of CD68, lysozyme, CD11c, and CD14 in addition to the lack of expression of B-cell, T cell, myeloid and follicular dendritic cell markers. It is alleged that CD163 and CD68 are the best markers for diagnosis [7] . In our cases, the tumor cells showed the histiocytic markers by IHC. Radiological imaging especially MRI is useful for staging purposes. Since most of these neoplasms have a solid yet smooth surface, the diagnosis usually relies on resected surgical specimens. The HS usually diagnosed at an advanced clinical stage, so response to therapy (either radiation or chemotherapy) is poor [11] . However, localized, early stage disease has a good prognosis [6] . Our case completely met these criteria. Principal treatment of HS consists of surgery with negative surgical margins, combined with radiation therapy. Chemotherapy has been added to previous therapies [12] . The clinical course of patients with HS is variable. Some correlation exists between stage and prognosis. Some authors have suggested that advanced stages correlate with poorer prognosis. Patients with localized disease may have long survival [6, 11] . In conclusion, cervical HS is a rare entity. Its clinical presentations are very similar to more common cervical tumors. As a result, clinical suspicion with well planned diagnostic procedures helps us diagnose this uncommon tumor. Diagnosis of HS relies mainly on morphology and immunohistochemical methods. A correct diagnosis could lead to the proper and timely treatment. 
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